MARISA KAISER: Open Payments
NPI 1558811471 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 11 payments from 7 companies in 2025. Trend: 2023 $391 · 2024 $440 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 5 | $99 |
| Hologic Sales and Service, LLC | 1 | $96 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Smith+Nephew, Inc. | 1 | $18 |
Products named: ZURZUVAE, NOVASURE, MYFEMBREE, LO LOESTRIN FE, GARDASIL 9, Veozah, "ACTICOAT 4"" X 4""".
Industry payments across AZ — which companies pay providers there.
